Literature DB >> 12119283

Inhibitory PAS domain protein (IPAS) is a hypoxia-inducible splicing variant of the hypoxia-inducible factor-3alpha locus.

Yuichi Makino1, Arvydas Kanopka, William J Wilson, Hirotoshi Tanaka, Lorenz Poellinger.   

Abstract

The inhibitory PAS (Per/Arnt/Sim) domain protein, IPAS, functions as a dominant negative regulator of hypoxia-inducible transcription factors (HIFs) by forming complexes with those proteins that fail to bind to hypoxia response elements of target genes. We have previously observed that IPAS is predominantly expressed in mice in Purkinje cells of the cerebellum and in corneal epithelium of the eye where it appears to play a role in negative regulation of angiogenesis and maintenance of an avascular phenotype. Sequencing of the mouse IPAS genomic structure revealed that IPAS is a splicing variant of the HIF-3alpha locus. Thus, in addition to three unique exons (1a, 4a, and 16) IPAS shares three exons (2, 4, and 5) with HIF-3alpha as well as alternatively spliced variants of exons 3 and 6. In experiments using normal mice and mice exposed to hypoxia (6% O(2)) for 6 h we observed alternative splicing of the HIF-3alpha transcript in the heart and lung. The alternatively spliced transcript was only observed under hypoxic conditions, thus defining a novel mechanism of hypoxia-dependent regulation of gene expression. Importantly, this mechanism may establish negative feedback loop regulation of adaptive responses to hypoxia/ischemia in these tissues.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12119283     DOI: 10.1074/jbc.C200328200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  95 in total

1.  Properties of switch-like bioregulatory networks studied by simulation of the hypoxia response control system.

Authors:  Kurt W Kohn; Joseph Riss; Olga Aprelikova; John N Weinstein; Yves Pommier; J Carl Barrett
Journal:  Mol Biol Cell       Date:  2004-04-23       Impact factor: 4.138

Review 2.  Hypoxia-inducible factors regulate T cell metabolism and function.

Authors:  Anthony T Phan; Ananda W Goldrath
Journal:  Mol Immunol       Date:  2015-08-19       Impact factor: 4.407

3.  Peroxisomal localization of hypoxia-inducible factors and hypoxia-inducible factor regulatory hydroxylases in primary rat hepatocytes exposed to hypoxia-reoxygenation.

Authors:  Zahida Khan; George K Michalopoulos; Donna Beer Stolz
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

Review 4.  Cellular oxygen sensing in health and disease.

Authors:  David R Mole; Peter J Ratcliffe
Journal:  Pediatr Nephrol       Date:  2007-10-23       Impact factor: 3.714

Review 5.  Metabolic requirements for the maintenance of self-renewing stem cells.

Authors:  Keisuke Ito; Toshio Suda
Journal:  Nat Rev Mol Cell Biol       Date:  2014-04       Impact factor: 94.444

Review 6.  Novel approaches in the therapy of metastatic renal cell carcinoma.

Authors:  John S Lam; John T Leppert; Arie S Belldegrun; Robert A Figlin
Journal:  World J Urol       Date:  2005-04-05       Impact factor: 4.226

Review 7.  Oxidative stress is fundamental to hyperbaric oxygen therapy.

Authors:  Stephen R Thom
Journal:  J Appl Physiol (1985)       Date:  2008-10-09

Review 8.  Generating specificity and diversity in the transcriptional response to hypoxia.

Authors:  Urban Lendahl; Kian Leong Lee; Henry Yang; Lorenz Poellinger
Journal:  Nat Rev Genet       Date:  2009-11-03       Impact factor: 53.242

Review 9.  Enzyme substrate recognition in oxygen sensing: how the HIF trap snaps.

Authors:  Eric Metzen
Journal:  Biochem J       Date:  2007-12-01       Impact factor: 3.857

10.  Alternative splicing in the differentiation of human embryonic stem cells into cardiac precursors.

Authors:  Nathan Salomonis; Brandon Nelson; Karen Vranizan; Alexander R Pico; Kristina Hanspers; Allan Kuchinsky; Linda Ta; Mark Mercola; Bruce R Conklin
Journal:  PLoS Comput Biol       Date:  2009-11-06       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.